tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Monopar Therapeutics Inc (MNPR) Stock Investors

325 Followers
Based on 722,977 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MNPR
On average, investors allocate 0.00% of their portfolios to MNPR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,977 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MNPR

4.2%
Last 7
Days
1.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MNPR, out of 722,977 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MNPR Investor Activity

No data currently available
Based on the activity of 13,596 investors who made their portfolios public
The table shows changes in MNPR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MNPR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
-0.16%
+1.13%
41.01B
Consumer Cyclical
Coherus Biosciences
2.68%
-0.92%
-3.42%
253.91M
Healthcare
Assertio Therapeutics
2.70%
-1.25%
-4.65%
98.80M
Healthcare
ChargePoint Holdings
3.94%
-1.55%
-3.54%
723.19M
Consumer Cyclical
Merck & Company
4.06%
+0.21%
+0.71%
317.37B
Healthcare
Marathon Digital Holdings
5.68%
-0.85%
+6.82%
5.92B
Financial
Micron
5.70%
+11.23%
+26.64%
129.71B
Technology
AMC Entertainment
5.37%
-0.95%
-3.75%
1.08B
Communication Services
Plug Power
4.91%
-1.00%
+0.08%
2.28B
Industrials
Riot Platforms
5.08%
+0.62%
+5.27%
3.15B
Financial
Based on the activity of 722,977 active portfolios
Open your Smart Portfolio

MNPR Investor Analysis

MNPR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
16.9%
of MNPR holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
MNPR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.2%
of MNPR holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
MNPR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.8%
of MNPR holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of MNPR stock investors
See who invests in MNPR according to age group and performance.

FAQ

How many retail Investors hold MNPR?
<0.1% of TipRanks' retail investors hold MNPR in their portfolios.
    What is MNPR Investor Sentiment?
    MNPR’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of MNPR in the last 7 days?
      ▼ 4.2% of TipRanks' retail investors changed their holding of MNPR in the last 7 days.
        What percentage of retail investors changed their holding of MNPR in the last 30 days?
        ▲ 1.2% of TipRanks' retail investors changed their holding of MNPR in the last 30 days.
          What is the average age of retail investors who hold MNPR?
          The average age of MNPR Holders is between 35–55.
            What other stocks have MNPR investors also bought?
            MNPR Investors also bought DKNG, CHRS, ASRT, CHPT, MRK, MARA, MU, AMC, PLUG, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis